Medhini-Arficus

Medhini-Arficus is an Indian-based startup founded in 2019 that offers an Artificial Intelligence Disease Screening/Diagnostics/Prediction SaaS-SAMD platform. The company provides AI-based accurate disease diagnosing for a wide range of diseases including Monkey pox, Otitis media, Melanoma, carcinoma, Covid, and more, as well as pre-screening of diseases and support for cure and treatment. Their services also include patient future disease prediction modeling and susceptibility analysis based on current co-morbidities/lifestyle/drug effects, and support for new drug discovery analysis. The target market for Medhini-Arficus includes healthcare establishments such as primary healthcare centers, rural areas, diagnostic centers, dental clinics, and hospitals, with the company aiming to provide a "HOSPITAL ON THEIR MOBILE IN THEIR POCKET" mechanism. Additionally, the market size is estimated at $10 billion. The company's solutions are based on artificial intelligence and offer quick diagnosing and treatment, hand-hold support for the entire medical journey, and user-friendly, high-quality healthcare technology. The startup received a non-equity assistance investment from JioGenNext on 16 February 2024. Their offerings include an AI-based diagnosing solution in just 53 seconds, data-driven genome sequencing, pandemic wave prediction analysis, as well as Whatsapp and voice-based testing, and web/mobile-based early disease diagnosing.